Drugmaker Natco Pharma on Friday, 13 November 2026, reported a sharp fall in earnings for the July–September quarter, with consolidated net profit dropping about 61% from a year earlier as revenue shrank.

The company said its net profit for the quarter ended 30 September 2026, the second quarter of financial year 2026-27, came in at Rs 202.6 crore, compared with Rs 517.9 crore in the same quarter last year. That works out to a decline of 60.8%.

Revenue down nearly a third

Revenue from operations slipped to Rs 967.3 crore from Rs 1,363 crore a year ago, a fall of roughly 29%. According to reports of the company's filing, the lower revenue was the main drag on profit during the quarter.

Costs also came down, but not by nearly as much. Total expenses for the quarter stood at Rs 776.2 crore, against Rs 849.3 crore in the corresponding period of the previous year. With revenue falling much faster than spending, the gap between the two narrowed considerably, squeezing the bottom line.

First-half picture

The weakness was not limited to a single quarter. For the April–September 2026 half-year, Natco's consolidated net profit stood at Rs 409.1 crore, down 59% from Rs 998.2 crore in the first half of the previous financial year.

Dividend and stake purchase

Despite the drop in earnings, the company's board approved an interim dividend of Rs 1.25 per equity share with a face value of Rs 2 each.

Natco also disclosed that during the quarter it bought an additional 13.25% stake in Adcock Ingram Holdings. Reports of the filing noted that the company did not spell out what effect the purchase had on the quarter's earnings.

How the market reacted

Investors appeared to take the numbers in their stride. Natco's shares ended Friday's trading session 0.22% lower at Rs 807 on the BSE.

Why it matters

A fall of this scale in both revenue and profit in a single quarter is significant for a listed drugmaker. The results show that savings on expenses were not enough to offset a steep slide in sales in the quarter, and the half-yearly numbers indicate the pressure has persisted through the first six months of the financial year.

What to watch next

Investors will be looking at whether revenue stabilises in the October–December quarter and how the enlarged holding in Adcock Ingram feeds into Natco's consolidated accounts in the coming quarters. The company's next set of quarterly numbers, for the period ending 31 December 2026, will offer the first indication of whether the downturn is bottoming out.

PS